#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    NTRK gene fusion overexpression Pyruvate dehydrogenase complex deficiency B-cell small lymphocytic lymphoma refractory Immune-mediated enterocolitis Heavy menstrual bleeding Inflammatory myofibroblastic tumour Dupuytren's contracture Nephrotic syndrome Fallopian tube cancer Small cell lung cancer Usher's syndrome Retinopathy proliferative Cervix carcinoma recurrent Thrombocytosis Choroidal dystrophy More trials…

    Learn about Rare Diseases

    Thrombotic thrombocytopenic purpura – Diagnostics MELAS syndrome Optic glioma – Basic Information Marfan’s syndrome – Trials in Disease Malignant fibrous histiocytoma – Treatment Small intestine leiomyosarcoma – Treatment Rhabdoid tumour – Trials in Disease Sarcoidosis – Basic Information Undifferentiated sarcoma – Trials in Disease Pulmonary sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Dipropionate Nebivolol Hydrochloride Ioflupane (123I) Tildrakizumab His203-Crm197 Dapagliflozin Albaconazole INOBRODIB Incb000928 Clofazimine Etravirine 89ZR-CED88004S Vanglusagene Ensiparvovec Posaconazole Gsk3739937 Lepidoglyphus Destructor Hydrocortisone Iti-1284 Radotinib Dihydrochloride Sodium Hypochlorite More therapies…

    Learn about Your Condition

    Chronic fatigue syndrome Back pain Osteoporosis postmenopausal Metastases to rectum Trisomy 21 Short stature Pulmonary embolism Pseudomonas infection Somatic symptom disorder Brain neoplasm Systemic sclerosis pulmonary Immune system disorder Laryngeal cancer stage I Thromboangiitis obliterans Neurodevelopmental disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System and Oral Physiological Phenomena

  • A Study Comparing Human Albumin and Saline Solution for Treating Kidney Injury in Patients with Advanced Liver Cirrhosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    • Sodium Chloride
    Spain

  • Study on Using Fluorescein Sodium to Identify Inflammation in Crohn’s Disease Patients During Ileal Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Fluorescein Sodium
    France

  • Study on Indocyanine Green for Patients Undergoing Emergency Surgery for Acute Cholecystitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholecystitis acute
    Investigated Drugs:
    • Indocyanine Green
    Spain

  • Study on the Effectiveness of FOLFIRINOX and FOLFOX for Patients with Advanced Small Bowel Cancer Using Calcium Levofolinate, Irinotecan, and Oxaliplatin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small intestine adenocarcinoma
    Investigated Drugs:
    • Calcium Levofolinate
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    France Italy

  • Study on Crohn’s Disease: Evaluating Risankizumab’s Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

    Recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Belgium Bulgaria Czechia France Germany Italy +4

  • Study of prucalopride in patients with gastro-esophageal reflux disease who have incomplete response to standard acid-reducing therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastrooesophageal reflux disease
    Investigated Drugs:
    • Prucalopride
    Belgium
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!